Related Experiment Video
Updated: Jun 14, 2026
09:09
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
Biodegradable nano-polymeric system for efficient Akt1 siRNA delivery.
Dhananjay Jere1, Rohidas Arote, Hu-Lin Jiang
1Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Korea.
Journal of Nanoscience and Nanotechnology
|April 3, 2010
Summary
Biodegradable nano-polymeric carriers (BNPP) effectively deliver small interfering RNA (siRNA) to lung cancer cells. This targeted delivery silences Akt1, reducing cancer cell survival, proliferation, and metastasis.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Biology
Background:
- Lung cancer remains a leading cause of cancer-related deaths worldwide.
- Effective delivery of therapeutic nucleic acids, such as small interfering RNA (siRNA), is crucial for cancer treatment.
- Developing safe and efficient carriers for siRNA delivery is a significant challenge in nanomedicine.
Purpose of the Study:
- To synthesize and characterize a novel biodegradable nano-polymeric carrier (BNPP) for siRNA delivery.
- To evaluate the efficiency and safety of BNPP in delivering siRNA to lung cancer cells.
- To investigate the therapeutic effect of BNPP-mediated Akt1 siRNA delivery on lung cancer progression.
Main Methods:
- Synthesis of biodegradable nano-polymeric carrier (BNPP) using polycaprolactone (PCL) and polyethylenimine (PEI).
- In vitro evaluation of BNPP's efficiency and safety in delivering siRNA to lung cancer cells.
- Assessment of Akt1 protein silencing and its impact on cancer cell survival, proliferation, malignancy, and metastasis following BNPP-delivered Akt1 siRNA treatment.
Main Results:
- Successful synthesis of BNPP, a biodegradable nano-polymeric carrier.
- BNPP demonstrated efficient and safe delivery of siRNA in lung cancer cells.
- BNPP-delivered Akt1 siRNA effectively silenced Akt1 protein expression.
- Silencing of Akt1 led to reduced cancer cell survival, proliferation, malignancy, and metastasis.
Conclusions:
- BNPP is a promising biodegradable carrier for targeted siRNA delivery in lung cancer therapy.
- BNPP-mediated Akt1 siRNA delivery offers a potential strategy to inhibit lung cancer progression.
- Further research into BNPP-based nanomedicines could lead to novel lung cancer treatments.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.